SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Astellas Pharma US Submits U.S. New Drug Application for Tacrolimus Extended Release Capsules, a Prophylaxis of Organ Rejection in Transplant Recipients